Atrial natriuretic peptide ameliorates peritoneal fibrosis in rat peritonitis model (Q44364802)

2 December 2017

Atrial natriuretic peptide ameliorates peritoneal fibrosis in rat peritonitis model (English)

1 reference

atrial natriuretic peptide

2 December 2017

0 references

sclerosing encapsulating peritonitis

1 reference

3

Masashi Mizuno

1 reference

2 December 2017

12

Yasuhiko Ito

1 reference

2 December 2017

11

Seiichi Matsuo

1 reference

2 December 2017

8

Shoichi Maruyama

1 reference

2 December 2017

5

Yasuhiro Suzuki

1 reference

2 December 2017

2

Tomohiro Mizuno

1 reference

2 December 2017

Hiroshi Kato

1

1 reference

2 December 2017

Akiho Sawai

4

1 reference

2 December 2017

Hiroshi Kinashi

6

1 reference

2 December 2017

Fumiko Nagura

7

1 reference

2 December 2017

Yukihiro Noda

9

1 reference

2 December 2017

Kiyofumi Yamada

10

1 reference

2 December 2017

language of work or name

English

0 references

publication date

9 June 2011

1 reference

Nephrology Dialysis Transplantation

2 December 2017

1 reference

2 December 2017

27

1 reference

2 December 2017

2

1 reference

2 December 2017

526-536

1 reference

Functional longevity of the human peritoneum: how long is continuous peritoneal dialysis possible? Results of a prospective medium long-term study.

2 December 2017

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR302

An autopsy study of the peritoneal cavity from patients on continuous ambulatory peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR302

The renin-angiotensin-aldosterone system in peritoneal dialysis: is what is good for the kidney also good for the peritoneum?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR302

Mineralocorticoid receptor blockade ameliorates peritoneal fibrosis in new rat peritonitis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR302

The ACE inhibitor, quinapril, ameliorates peritoneal fibrosis in an encapsulating peritoneal sclerosis model in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR302

Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR302

Cardiac-specific attenuation of natriuretic peptide A receptor activity accentuates adverse cardiac remodeling and mortality in response to pressure overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR302

The role of natriuretic peptides in cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR302

Gene expression of natriuretic peptide receptors in myocardial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR302

Atrial natriuretic peptide suppresses endothelin gene expression and proliferation in cardiac fibroblasts through a GATA4-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR302

Increased susceptibility to heart failure in response to volume overload in mice lacking natriuretic peptide receptor-A gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR302

Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR302

Cardiac fibrosis in mice lacking brain natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR302

Atrial natriuretic peptide dose-dependently inhibits pressure overload-induced cardiac remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR302

Volume overload results in exaggerated cardiac hypertrophy in the atrial natriuretic peptide knockout mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR302

Effect of neutral endopeptidase inhibitor on endogenous atrial natriuretic peptide as a paracrine factor in cultured cardiac fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR302

Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR302

Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR302

Atrial natriuretic peptide helps prevent late remodeling after left ventricular aneurysm repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR302

Lack of the growth factor midkine enhances survival against cisplatin-induced renal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR302

Natriuretic peptides inhibit angiotensin II-induced proliferation of rat cardiac fibroblasts by blocking endothelin-1 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR302

Atrial natriuretic peptide reduces vascular leakage and choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR302

Connective tissue growth factor (CTGF/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR302

Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR302

Synthetic human alpha-atrial natriuretic peptide infusion in management after open heart operations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR302

Transgenic overexpression of brain natriuretic peptide prevents the progression of diabetic nephropathy in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR302

Angiotensin II induces fibronectin expression in human peritoneal mesothelial cells via ERK1/2 and p38 MAPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR302

Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR302

Angiotensin II increases connective tissue growth factor in the kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR302

Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR302

21 January 2018

Identifiers

DOI

10.1093/NDT/GFR302

1 reference

2 December 2017

1 reference